117 Days
المصدر:
صحة
Brazil approves first generic for Ozympic
Novo Nordisk is facing pressure from a new local competitor offering products at prices 30% lower, which is affecting the company's profits.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading